Year: 2020

Affordable treatment will soon be available for children living with HIV in low- and middle-income countries thanks to an agreement between the global health agency UNITAID and the Clinton Health Access Initiative, or CHAI.The pediatric  treatment has been available in wealthy countries but out of reach for children in poor countries. A new agreement with two generic drug makers, Viatris and Macleods, will significantly lower the price. UNITAID and CHAI plan to roll out the first anti-retroviral treatments specifically designed for children next year in six African countries — Benin, Kenya, Malawi, Nigeria, Uganda and Zimbabwe. FILE – A mother watches her HIV-positive child in the intensive care unit of the Bangui pediatric complex, while in the foreground, an HIV-positive child sleeps, in Central African Republic, Dec. 4, 2018.An estimated 1.7 million children globally live with HIV, but only half receive any treatment and 100,000 die every year.   UNITAID spokesman Herve Verhoosel said HIV is not suppressed for many of those children. That is due, in part, to the lack of availability of effective drugs that are properly adapted for them.   “Many children who are living with HIV have a poor response to treatment because they take anti-retroviral medication that are not correctly dosed or bitter to taste. … Now with this new drug … it will be much, much easier and much, much less expensive,” he said, adding that even the youngest children will like the strawberry-flavored pills.   Under the new pricing agreement, the cost for the yearly pediatric HIV treatment …

Members of a U.S. Centers for Disease Control and Prevention advisory committee are meeting Tuesday to determine who should get inoculated first against the coronavirus once a vaccine receives final approval.The CDC’s Advisory Committee for Immunization Practices wants to inform the public about its recommendation before a decision is announced by the U.S. Food and Drug Administration, committee chairman Dr. Jose Romero told CNN on Tuesday.The FDA is considering an emergency request from Pfizer to authorize the use of its vaccine. Moderna said Monday it also would apply for emergency use authorization of its vaccine.The CDC has already recommended that front-line health care workers and support personnel receive the first doses. The CDC also said residents of nursing homes and other long-term care facilities should be among the first to receive vaccinations.Hours after Moderna’s announcement, Health and Human Services Secretary Alex Azar said the agency would announce its decision up to a week after it decides on Pfizer’s application.Dr. Larry Corey of the University of Washington, who leads vaccine clinical trials in the U.S., has said once Pfizer’s and Moderna’s vaccines are approved, they could make 50 million doses in January.The advisory committee is meeting one day after nearly 139,000 new coronavirus cases and 826 deaths were reported in the U.S., according to Johns Hopkins University.As it has for months, the U.S. continues to lead the world in coronavirus infections, with more than 13.5 million of the world’s 63.3 million cases. Over 268,000 people have died of COVID-19 in the U.S., …

Climate change, voracious beetles and disease are imperiling the long-term survival of a high-elevation pine tree that’s a key source of food for some grizzly bears and found across the West, U.S. officials said Tuesday.A Fish and Wildlife Service proposal scheduled to be published Wednesday would protect the whitebark pine tree as a threatened species under the Endangered Species Act, according to documents posted by the Office of the Federal Register.But the agency said it does not plan to designate which forest habitats are critical to the tree’s survival, stopping short of what some environmentalists argue is needed.Live in harsh conditionsThe trees can live up to 1,000 years and are found at elevations up to 12,000 feet (3,600 meters) — conditions too harsh for most tress to survive.Environmentalists had petitioned the government in 1991 and again in 2008 to protect the trees, which occur across 126,000 square miles (326,164 square kilometers) of land in Wyoming, Montana, Idaho, Washington, Oregon, California, Nevada and western Canada.A nonnative fungus has been killing whitebark pines for a century. More recently, the trees have proven vulnerable to bark beetles that have killed millions of acres of forest, and climate change that scientists say is responsible for more severe wildfire seasons.The trees have been all but wiped out in some areas, including the eastern edge of Yellowstone National Park, where they are a source of food for threatened grizzly bears. More than half of whitebark pines in the U.S. are dead, according to a 2018 study …

The China National Space Administration (CNSA) has announced its Chang’e-5 spacecraft, designed to collect lunar samples and return them to Earth, successfully landed on the near side of the moon. China state media report the spacecraft arrived at the preselected landing area Tuesday and sent back images to the CNSA.  The spacecraft – composed of orbiter, lander, ascender and returner components – was launched a week ago.  The CNSA said the lander-ascender combination of the Chang’e-5 probe began a powered descent from about 15 kilometers above the lunar surface. They say the probe touched down on the north of the region known as Mons Rumker in Oceanus Procellarum, also called the Ocean of Storms, on the near side of the moon. Under ground control, the lander carried out a series of status checks and settings, preparing for about 48 hours of work on the lunar surface. The space agency said about 2 kilograms of samples are expected to be collected and sealed in a container. Then the ascender will take off and dock with the orbiter-returner combination in orbit. After the samples are transferred to the returner, the ascender will separate from the orbiter-returner. The orbiter is expected to carry the returner back to Earth. The returner is scheduled to reenter the atmosphere and land at Siziwang Banner in north China’s Inner Mongolia Autonomous Region.  …

All Europeans want is a merry and bright Christmas season, just like the ones they used to know. And under public pressure some governments are easing their pandemic restrictions in a bid to salvage something of the holiday spirit.But as some governments plan to soften restrictions by increasing the number of separate households permitted to socialize and allowing people to travel, others are still grappling with how far they should go in easing lockdowns or lifting curfews, fearing that having a merry Christmas will likely mean suffering a miserable new year.Scientists across the continent, which already accounts for a quarter of the world’s coronavirus cases and deaths from COVID-19, the disease triggered by the virus, are warning of a doubling in infection rates, if the regime for the holiday is too liberal.European Commission President Ursula von der Leyen last week said it was important for European states to coordinate any easing of pandemic restrictions. “We will make a proposal for a gradual and coordinated approach to lifting containment measures. This will be very important to avoid the risk of yet another wave,” von der Leyen said.European Commission President Ursula von der Leyen, top, European Central Bank President Christine Lagarde, European Council President Charles Michel and Eurogroup President Paschal Donohoe attend a virtual meeting in Brussels, Nov. 26, 2020.Despite her call for coordinated action, national governments are making up their own minds without synchronizing approaches — as they have ever since the pandemic first struck the continent earlier this year. Many …

Members of a U.S. Centers for Disease Control and Prevention advisory committee meet Tuesday to determine who should get inoculated first against the coronavirus once a vaccine receives final approval.The CDC’s Advisory Committee for Immunization Practices wants to inform the public about its recommendation before a decision is announced by the U.S. Food and Drug Administration, committee chairman Dr. Jose Romero told CNN on Tuesday.The FDA is considering an emergency request from Pfizer to authorize the use of its vaccine. Moderna said Monday it also would apply for emergency use authorization of its vaccine.The CDC has already recommended that front-line health care workers and support personnel receive the first doses. The CDC also said residents of nursing homes and other long-term care facilities should be among the first to receive vaccinations.Hours after Moderna’s announcement, Health and Human Services Secretary Alex Azar said the agency would announce its decision up to a week after it decides on Pfizer’s application.Dr. Larry Corey of the University of Washington, who leads vaccine clinical trials in the U.S., has said once Pfizer’s and Moderna’s vaccines are approved, they could make 50 million doses in January.The advisory committee meets one day after nearly 139,000 new coronavirus cases and 826 deaths were reported in the U.S., according to Johns Hopkins University.As it has for months, the U.S. continues to lead the world in coronavirus infections, with more than 13.5 million of the world’s 63.3 million cases. Over 268,000 people have died of COVID-19 in the U.S., more …

Thabani Raymond Kalala, or “coach,” as he prefers to be called, was diagnosed with HIV six years ago. He lives in a small town in rural South Africa, but this year, as societies across the globe went into viral lockdowns, his world expanded.  The 33-year-old community development worker was part of a pilot project called Coach Mpilo — the word means “life,” or “health” in isiZulu. As a “coach,” he works with 54 newly diagnosed men and boys, supporting their battle against HIV and boosting them, in ways big and small.The launch of the project, earlier this year, coincided with the beginning of global shutdowns to stop the spread of coronavirus. However, he says, that hasn’t slowed down progress.  “I think the program has been successful,” he told VOA by phone from his rural village along South Africa’s southern coast. “However, the challenge is, we had to cut down many people, actually we had to cut down many coaches. … We need to try, I’m not sure if this is possible, but if we can get more coaches, because the program has been very successful to such an extent that even the facilities that we work in have seen the difference that we’ve been doing.”Laboratory technicians test a blood sample for HIV infection at the Reproductive Health and HIV Institute (RHI) in Johannesburg, Nov. 26 2020.This small initiative is one of the ways that, 40 years after the emergence of AIDS, the nation with the world’s heaviest burden of HIV …

The European Union said Tuesday it could be vaccinating citizens against COVID-19 by the end of the month if medical officials grant emergency approval of two vaccines candidates.  European Commission President Ursula Von der Leyen told reporters in Brussels EU member states are working on logistics for the distribution of millions of doses of COVID-19 vaccine and if all goes well, she said, “the first European citizens would be vaccinated by the end of December.”Her comments came as U.S. pharmaceutical company Pfizer and its German partner BioNTech announced they have applied for conditional approval of their coronavirus vaccine with the European Medicines Agency. The companies said in a statement that the submission on Monday completes the rolling review process they initiated with the agency on October 6.The move comes a day after another U.S company, Moderna said it was asking U.S. and European regulators to allow emergency use of its COVID-19 vaccine. Both companies applied with the U.S. Food and Drug Administration (FDA) for emergency approval in November.In a statement, the European Medicines Agency said it would convene a meeting on December 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved.The agency also said Tuesday it could decide as early as January 12 whether to approve a COVID-19 vaccine developed by Moderna.Last week, the EU said it had signed deals to acquire more than a billion doses of a total of six …

Four years ago, governments around the world committed to achieving targets in testing and treating the vast majority of people with HIV to the point where the AIDS pandemic would end. The tools to do this have been available for 20 years. In 2010, the National Institutes of Health, under the leadership of Dr. Anthony Fauci, found that HIV-negative men whose partners were positive, significantly reduced their chances of becoming infected by taking a daily pill that combined anti-AIDS medication. This has become known as pre-exposure prophylaxis or PrEP. PrEP can now be given as an injection. And people with HIV can take a single pill that makes the human immunodeficiency virus (HIV) in the blood undetectable. Under Dr. Demetre Daskalakis’ direction, the goal by the United Nations in 2016 was achieved in New York City, but Dr. Chris Beyrer, an AIDS researcher at Johns Hopkins University, says it is way off track elsewhere. Beyrer spoke to VOA recently. His questions have been edited for brevity and clarity. VOA: Where are we in achieving the universal goals of having 90% of people with HIV diagnosed, 90% of those diagnosed on treatment, and 90% of those on treatment being able to suppress the virus to undetectable levels? Beyrer: “The 90-90-90 targets were based on the assumption that achieving those goals would also bring down the rate of new infections, because as more people are treated, and are successfully virally suppressed, they will be less infectious for sex partners or maternal-to-child transmission. “2020 was supposed to be the year in which we were going to see significant declines in new infections down under 500,000 worldwide, and we had more than 1.7 million new infections in 2019. So, we are way off the targets of actually getting control of HIV transmission.” VOA: Why are we way off track?Beyrer: …

Dr. Demetre Daskalakis will soon leave his position as deputy commissioner for disease control at the New York City Department of Health and move to the Centers for Disease Control and Prevention in Atlanta, where he will oversee the U.S. HIV/AIDS prevention office.   In New York, Daskalakis designed a plan that helped the city achieve the U.N. goals of 90-90-90, meaning that 90% of those with HIV were tested, 90% of those tested went on treatment and 90% of those in treatment saw their viral levels drop so low the virus was undetectable in the blood stream and they could not infect anyone else. Achieving this goal would effectively end HIV/AIDS.  In New York, Governor Andrew Cuomo detailed a plan called Ending the AIDS Epidemic throughout the state. Under Daskalakis’ guidance in New York City, this program reduced AIDS-related illnesses from the third-leading cause of premature death in 2000 to the 10th by 2017.He spoke recently with VOA. His interview has been edited for brevity and clarity.  VOA: The Ending the Epidemic program in New York City is credited with decreasing HIV transmissions to a historic low. How did you do that?  Dr. Demetre Daskalakis: “It took a village; many, many people, and the very first people that helped design the program were actually the community and advocates that let me and others really know where we had gaps. “Ending the Epidemic program in the city was really a supplemental strategy that added to the programs that were already working through CDC funding as well as through HERSA funding the Ryan White.  (The Health Resources and Services Administration (HRSA), an agency of the U.S. …

Four years ago, governments around the world committed to U.N. goals that would end the AIDS pandemic. VOA’s Carol Pearson tells us why these goals are so elusive, and how a major city succeeded. …

Tuesday is World AIDS Day, with organizations around the world highlighting the need to support those living with and affected by HIV, the virus that causes the disease, while also remembering those who have died. This year’s event comes amid the global coronavirus pandemic, which UNAIDS says has made it more difficult for those living with HIV to access health care and other services while also highlighting issues such as inequality and stigma. The agency is calling on governments to boost investment and action on HIV and other pandemics.  It says if there were better health and social safety nets in place, the world would have been better able to slow the spread of the coronavirus.Laboratory technicians test a blood sample for HIV infection at the Reproductive Health and HIV Institute (RHI) in Johannesburg, Nov. 26 2020.The United Nations said models show there could be an additional 123,000 to 293,000 new HIV infections and between 69,000 and 148,000 AIDS-related deaths by 2022 because of the coronavirus pandemic’s effects on HIV responses. “The collective failure to invest sufficiently in comprehensive, rights-based, people-centered HIV responses has come at a terrible price,” UNAIDS Executive Director Winnie Byanyima said in a statement. “Implementing just the most politically palatable programs will not turn the tide against COVID-19 or end AIDS. To get the global response back on track will require putting people first and tackling the inequalities on which epidemics thrive.” The joint challenges of HIV/AIDS and the coronavirus are also the focus of a live-streamed event Tuesday by the National AIDS Memorial in the United States.  It includes …

Joseph Varon, a doctor treating coronavirus patients at a Texas hospital, was working his 252nd day in a row when he spotted a distraught elderly man in the COVID-19 intensive care unit. Varon’s comforting embrace of the white-haired man on Thanksgiving Day was captured by a photographer for Getty Images and has gone viral around the world. Varon, chief of staff at United Memorial Medical Center in Houston, told CNN he was entering the COVID-19 ICU when he saw the elderly patient “out of his bed and trying to get out of the room.” “And he’s crying,” Varon said. “So I get close to him and I (ask) him, ‘Why are you crying?’” “And the man says, ‘I want to be with my wife.’ So I just grab him and I hold him,” Varon said. “I was feeling very sorry for him. I was feeling very sad, just like him.” “Eventually he felt better, and he stopped crying,” Varon told CNN on Monday. “I don’t know why I haven’t broken down,” the doctor said. “My nurses cry in the middle of the day.” Varon said the isolation of the COVID-19 unit was difficult for many patients, particularly the elderly. COVID-19 is the disease caused by the coronavirus. “You can imagine,” he said. “You are inside a room where people are coming in spacesuits. “When you are an elderly individual, it’s more difficult because you are alone,” he said. “Some of them cry. Some of them try to escape,” he said. “We actually had somebody who tried to escape through a …

China has provided North Korean leader Kim Jong Un and his family with an experimental coronavirus vaccine, a U.S. analyst said Tuesday, citing two unidentified Japanese intelligence sources. Harry Kazianis, a North Korea expert at the Center for the National Interest think tank in Washington, said the Kims and several senior North Korean officials had been vaccinated. It was unclear which company had supplied its drug candidate to the Kims and whether it had proven to be safe, he added. FILE – North Korean leader Kim Jong Un speaks in Pyongyang, North Korea, in this undated photo released Nov. 16, 2020, by KCNA.”Kim Jong Un and multiple other high-ranking officials within the Kim family and leadership network have been vaccinated for coronavirus within the last two to three weeks thanks to a vaccine candidate supplied by the Chinese government,” Kazianis wrote in an article for online outlet 19FortyFive. Citing U.S. medical scientist Peter J. Hotez, he said at least three Chinese companies were developing a coronavirus vaccine, including Sinovac Biotech Ltd, CanSinoBio and Sinophram Group. Sinophram says its candidate has been used by nearly 1 million people in China, although none of the firms was known to have publicly launched Phase 3 clinical trials of their experimental COVID-19 drugs. North Korea has not confirmed any coronavirus infections, but South Korea’s National Intelligence Service (NIS) has said an outbreak there cannot be ruled out as the country had trade and people-to-people exchanges with China, the source of the pandemic, before shutting the border in late January. Microsoft said …

The World Health Organization says it is very worried about the rapidly growing surge of coronavirus cases in in Brazil and Mexico.WHO chief Tedros Adhanom Ghebreyesus told reporters at his regular briefing in Geneva on Monday, “I think Brazil has to be very, very serious,” in combating the surge there. He echoed the same concern for Mexico, which he said was in “bad shape.””The number of cases doubled, and the number of deaths doubled. … We would like to ask Mexico to be very serious,” he said.Mexico’s cumulative COVID-19 death toll passed 100,000 on November 20, and the country has added more than 5.000 deaths since then.Dressed in protective gear to curb the spread of the new coronavirus, a medical worker attends to a patient at a military hospital set up to take care of COVID-19 patients in Mexico City, November 30, 2020.Brazil has recorded more than 172,000 deaths from COVID-19, second only to the United States, which has reported more than 267,000 deaths.On Monday, Brazil’s most populous state, Sao Paulo, ordered shops, bars and restaurants to limit themselves to 40% capacity to try to control the spread of the pathogen.Meanwhile, drugmaker Moderna said Monday it has requested emergency authorization in the U.S. and Europe to distribute its coronavirus vaccine after tests showed it is 94% effective.The request comes shortly after another drug company, Pfizer-BioNTech, sought the same emergency authorization. If granted, inoculations in the U.S. could begin as soon as mid-December.The Moderna and Pfizer requests for emergency use of their …

As French authorities prepare to roll out their COVID immunization strategy this week, they face skepticism in a country where surveys show many people do not trust the vaccine.France was among the nations of Europe taking the heaviest hit from the COVID-19 outbreak as more than 50, 000 people died of the virus.Like the rest of the world, hopes are high that vaccines will defeat the virus and enable people to go back to a normal life. The French immunization campaign is scheduled to start by the end of December with the elderly, people living in nursing homes and medical personnel slated to receive the first doses.In an address to the nation, French President Emmanuel Macron said a scientific committee would supervise the immunization campaign and a citizen group would be created to make sure the population is part of the process. Immunization against COVID-19 must be clear and transparent and information must be shared  on what is known and unknown, insists Macron, who stressed that immunization will not be mandatory in France.The government is worried that millions of French people will refuse coronavirus vaccine shots due as skepticism grows in the country. Fifty-nine percent of French people surveyed say they would not get vaccinated, according to an IFO poll published on Sunday.Prime Minister Jean Castex recently said his fear is that not enough French people will get vaccinated.Jean Paul Stahl, a French doctor of infectious diseases, said the numbers concern him.The professor explains there is a common fear of …

Drugmaker Moderna said Monday it is seeking emergency authorization in the United States and Europe to distribute its coronavirus vaccine after tests showed it is 94% effective.The U.S. biotechnology company’s request could mean that health workers will be able to inoculate patients against the virus as soon as mid-December with either of two coronavirus preventatives — Moderna’s or another equally successful test drug produced by the corporate tandem of Pfizer-BioNTech — if the companies win approval from drug regulators.Moderna said it conducted a 30,000-person clinical trial, and its results were on a par with the best pediatric vaccines.The drugmaker said that of the 196 volunteers who contracted COVID-19, 185 had received a placebo versus 11 who received the vaccine. Moderna reported 30 severe cases — all in the placebo group — including one COVID-19-related death. The Moderna and Pfizer requests for emergency use of their vaccines come as the number of coronavirus cases is surging in the U.S., where tens of thousands of new cases are being recorded daily.Health officials say they are especially worried about an even further spread of the virus because millions of people ignored warnings against traveling for last week’s Thanksgiving holiday and could travel again over the upcoming Christmas and New Year’s holiday weekends.Air travelers line up to go through a security checkpoint at Salt Lake City International Airport in Salt Lake City, Utah, Nov. 25, 2020.The U.S. has 4% of the world’s population but nearly a fifth of its recorded coronavirus deaths — more than …

From instant coffee to Cheetos, packaged cookies and energy bars, the U.S. military helped invent many of the snacks Americans love to eat.    The effort accelerated during World War II, when military scientists needed to develop compact yet nutritional ways to feed the troops.   “There was a tremendous need for the military to develop modern rations, and it ended up not only inventing a bunch of new food processing techniques but putting in place a food science research system that exists to this day,” says food writer Anastacia Marx de Salcedo, author of “Combat-Ready Kitchen: How the U.S. Military Shapes the Way You Eat”. “Out of that came a lot of new techniques and food, and after the war, those were incorporated into snack and convenience foods.” Those new techniques include high pressure processing, which makes uncooked food safe to eat. The process is routinely used in packaged foods like guacamole, salsa and hummus. Cheetos, one of America’s favorite cheesy, crunchy snacks, are made possible by the dehydration process the military worked on to remove the water from cheese. That gave cheese both a longer shelf life and made it lighter to transport to troops overseas. Energy bars are a snack food that resulted from a long period of development to produce a small and nutritionally dense emergency ration.Military scientists discovered that pet food companies were working on a way to make the water level low enough to prevent bacteria and fungi from being produced, making the food safe. “Once they figured that out, they …

An electric “aero-ambulance” that is estimated to be faster, safer and quieter than a helicopter has been developed by researchers in Australia.  The aero ambulance is called Vertiia. It is an electric, vertical takeoff and landing aircraft designed to get patients to the hospital quicker and more safely.   It is set for commercial release in 2023, and developers say it will be the world’s most efficient aircraft of its type for passenger and “aeromedical transport.”   The transfer of patients in remote parts of Australia can be slow. Often, they must be driven to an airport by ambulance, transferred onto a plane, and then back into another ambulance for delivery to the hospital. Vertiia aims to take them from door to door. It is built to cruise at a speed of 300 kilometers per hour and travel 250 kilometers powered by electric batteries before needing to recharge. It is also designed to travel nonstop for more than 800 kilometers using hydrogen as an alternative fuel. The project is a collaboration between the University of Sydney, the startup company AMSL Aero and the charity CareFlight. Associate Professor Dries Verstraete is an aerospace engineer from the University of Sydney.   His team is working to increase the aircraft’s efficiency through its aerodynamic and structural design and reduce its operating costs.  “Aero ambulances work by taking off vertically and tilting the wing to horizontal, to tilt it back before they land,” he said. “The advantage of this concept is that they are flying efficiently like an aircraft, but they can …

On World Malaria Day, the World Health Organization is calling on countries to step up the fight against malaria, saying the coronavirus pandemic threatens to reverse important gains made in efforts to control this deadly disease. Since 2000, the U.N.’s World Health Organization reports 1.5 billion malaria cases and 7.6 million deaths have been averted globally. Some of the greatest achievements were made in sub-Saharan Africa, which bears the brunt of this deadly disease spread by mosquitos. Additionally, the director of the WHO’s Global Malaria Program, Pedro Alonso, said 21 countries have eliminated malaria over the last two decades. Of these, he says 10 have been officially certified as malaria-free by the WHO. “That means that more than half of all the world’s endemic countries are within reach of elimination,” Alonso said. “In the beginning of the century, three countries had less than 10 cases per year. Now, we have 24 countries, which are literally one step away from elimination.”  Despite remarkable progress, however, the World Health Organization reports global gains have leveled off in recent years. This is because of insufficient funding and a lack of access to proven malaria control tools, such as insecticide-treated mosquito nets and preventive medicines for children. The emergence of the coronavirus pandemic is now posing an additional challenge to the malaria response. WHO’s regional director for Africa, Matshidiso Moeti, said the gains made in Africa over many years against poverty and disease risk being reversed by the virus responsible for the COVID-19 disease. “Already, malaria causes a 1.3 …

Two top U.S. coronavirus experts assured Americans Sunday that vaccines against the pandemic would soon become available but warned that not taking precautions against the spread of the virus before then could prove disastrous. “We should have enough vaccine by the end of the year to immunize 20 million Americans and we have to immunize for impact,” Admiral Brett Giroir, the White House virus testing chief, told CNN. “But the American people have to do the right things until we get that vaccine widely distributed.” FILE – Adm. Brett Giroir, director of the U.S. coronavirus diagnostic testing, testifies at a Senate committee hearing, on Capitol Hill, in Washington, June 30, 2020.Giroir described two prospective vaccines, which are now under review by the U.S. Food and Drug Administration, as “lifesaving,” saying, “This puts an end to the pandemic.” But until then, he said, “The American people have to do the right things until we get that vaccine widely distributed, wear a mask, avoid indoor crowded spaces, all the things you know.”   Giroir said he believes there will be a “smooth, professional transition” in handling the vaccine distribution from the administration of outgoing President Donald Trump to that of President-elect Joe Biden when he is set to be inaugurated on January 20. Dr. Anthony Fauci, the country’s top infectious disease expert, speaking to ABC’s “This Week” show, said, “Help is on the way,” and that the initial supply of vaccines might be available by mid-December. Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious …

The World Health Organization is urging people to get moving and keep moving for better health.  The U.N. health agency says physical activity can avert the deaths of up to 5 million people annually.  WHO statistics show 1 in 4 adults and 80% of adolescents do not do enough physical activity, and women and girls generally do less than men and boys.  This, the agency says, hurts both human health and the health of world economies.     The agency reports physical activity can help prevent heart disease, type-2 diabetes, and cancer; as well reduce cognitive decline, including Alzheimer’s disease.  It says physical inactivity also can put societies into an economic hole.  The global cost of direct health care is estimated at $54 billion, with an additional cost of $14 billion in lost productivity.      WHO Director for Health Promotion Ruediger Krech says it is never too late to begin moving.  He says any type of physical activity, including walking, cycling, dancing, household tasks and gardening can counteract the harm from sitting too long.     “WHO urges everyone to continue to stay active through the COVID-19 pandemic.  If we do not remain active, we run the risk of creating another pandemic of ill health as a result of sedentary behavior,”  he said.New WHO guidelines recommend adults engage in at least 150 to 300 minutes of moderate to vigorous aerobic activity per week, and an average of 60 minutes a day for children and adolescents.   For the first time, WHO’s unit head for physical activity, …

Jim, from Taiwan, slipped a face mask inside the greeting card he sent to Santa and marked “I (heart) u.” Alina, 5, asked in her Santa letter written with an adult’s help that he please use the front door when he drops in, because the back door is reserved for Grandma and Grandpa to minimize their risk of contamination.And spilling out her heavy little heart to “Dear Father Christmas,” 10-year-old Lola wrote that she is wishing “that my aunt never has cancer again and that this virus no longer exists.”“My mother is a care-giver and sometimes I am scared for her,” Lola explained, signing off her handwritten letter with, “Take care of yourself Father Christmas, and of the Elves.”The emotional toll wrought by the pandemic is jumping off pages in the deluge of “Dear Santa” letters now pouring into a post office in southwest France that sorts and responds to his mail from around the world.Postal workers who call themselves ‘Elves’ open envelopes addressed ‘Pere Noel’ — Father Christmas in French – – decorated with love hearts, stickers and glitter, in Libourne, southwest France, Monday, Nov. 23, 2020.Arriving by the tens of thousands, the letters, notes and cards — some mere scribbles, other elaborate labors of love in colored pens — are revealing windows into the tender minds of their young authors, and of adult Santa fans also asking for respite and happiness, at the tail end of a year of sickness and tumult.Like this letter from young Zoe, who …

British Prime Minister Boris Johnson is asking lawmakers to support new, tiered restrictions to keep the nation’s hospitals from becoming overwhelmed before a vaccine for the coronavirus can be approved and distributed.The new measures would put 99% of the country under the two highest restriction levels when the current rules end Tuesday. The new restrictions would last about a month.An increasing number of members of Johnson’s own Conservative Party are opposed. And on Saturday, London police broke up anti-lockdown, anti-vaccine protests, arresting more than 150 people in the process.The government hopes that a vaccine, the first doses of which could be in British hospitals by December 7, and mass testing could end the need for restrictions. Britain has suffered the worst COVID-19 outbreak in Europe, with more than 57,000 virus-related deaths, according to Johns Hopkins University. COVID-19 is the disease caused by the coronavirus.Parliament is to vote on Johnson’s new restrictions Tuesday.FILE – President-elect Joe Biden walks from his motorcade to speak to reporters in Wilmington, Del., Nov. 23, 2020.In the U.S., President-elect Joe Biden added three members to his COVID-19 advisory board.QualificationsBiden added Jane Hopkins, Jill Jim and David Michaels to “strengthen the board’s work and help ensure that our COVID-19 planning will address inequities in health outcomes and the workforce,” he said.Hopkins is a registered nurse specializing in mental health and also serves on Washington state’s COVID-19 task force.Jim is a member of the Navajo Nation and the executive director of its Department of Health. She has focused …